Find public news by keyword, exact ticker, category and date.
Open a ticker page for its news coverage. The news search below stays a text search.
7 results loaded, newest first. End of these results.
On Thursday, Cytokinetics (NASDAQ: CYTK ) discussed second-quarter financial results during its earnings call. The full transcript is provided below. This content is powered APIs. For comprehensive financial data and transcripts, visit View the webcast at Summary Cytokinetics reported strong commercial momentum for Myc
Uranium Energy (AMEX: UEC ) reported fourth-quarter financial results on Tuesday. The transcript from the company's fourth-quarter earnings call has been provided below. This transcript is brought to you APIs. For real-time access to our entire catalog, please visit for a consultation. View the webcast at Summary Urani
EXECUTIVE SUMMARY * TRUMP HAILS IRAN TALKS EVEN AS TEHRAN SETS 'FIRM POSITIONS': #0244e48b-2945-4b3b-8085-728a924ddf38 * ZELENSKY ASKS TRUMP FOR WINTER ARMS PACKAGE, EXPECTS ENERGY-CEASEFIRE PUSH: WSJ: #cddd3044-ae77-4efa-9233-fb28b1e6f368 * NAGEL SAYS 'VIGILANT' ECB MAY NEED MILDLY RESTRICTIVE RATES: #13be4029-5b8c-40
EXECUTIVE SUMMARY * TRUMP HAILS 'VERY GOOD' IRAN TALKS FOLLOWING ANNIHILATION THREAT - BBG: #cdbad0a1-5c8d-4cdb-9819-370162b99299 * ZELENSKY ASKS TRUMP FOR WINTER ARMS PACKAGE, EXPECTS ENERGY-CEASEFIRE PUSH - WSJ: #a4c79a68-e487-466b-a806-4885fa3200e0 * LASTING SHOCKS, FIRMING DEMAND REQUIRE FED ACTION - BARKIN - MNI
AeroVironment said first-quarter revenue was $480 million, funded backlog reached a record $1.5 billion and adjusted EBITDA was nearly $46 million. The company also booked $683 million and reaffirmed fiscal 2027 revenue guidance of $2.125 billion to $2.225 billion and adjusted EBITDA guidance of $305 million to $325 mi
DocuSign reported Q2 revenue of $876 million, up 9% year over year, with a 32% operating margin and about $300 million in free cash flow. It also raised fiscal 2027 ARR guidance and said IAM now accounts for 15.1% of total ARR.
() -- Stronger data and resilient markets have improved the Bank of Canada's near-term outlook, but not its medium-term view, allowing economists to predict the central bank will remain on hold through the rest of 2026. The BoC on Wednesday decided to leave rates on hold for the sixth-consecutive policy meeting as it a